Syndrome News and Research

RSS
Screening drug candidates for COVID-19 treatment using computational methods

Screening drug candidates for COVID-19 treatment using computational methods

Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers

Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers

Study identifies COVID-19 vaccine inequity in Massachusetts

Study identifies COVID-19 vaccine inequity in Massachusetts

Just one mRNA vaccine dose sufficient for people with prior SARS-CoV-2 infection

Just one mRNA vaccine dose sufficient for people with prior SARS-CoV-2 infection

Researchers show how to evaluate waning efficacy of COVID-19 vaccines

Researchers show how to evaluate waning efficacy of COVID-19 vaccines

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

Researchers decipher the molecular underpinning of exceptional responses in glioblastoma patients

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

One dose of mRNA vaccine may be sufficient for individuals previously infected with SARS-CoV-2

Occurrence and persistence of SARS-CoV-2 in wastewater

Occurrence and persistence of SARS-CoV-2 in wastewater

Researchers reveal long-term kinetics of anti-SARS-CoV-2 antibodies in patient sera

Researchers reveal long-term kinetics of anti-SARS-CoV-2 antibodies in patient sera

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Researchers develop computational model to predict changes in SARS-CoV-2’s viral fitness

Could a tuna-derived protein inhibit SARS-CoV-2?

Could a tuna-derived protein inhibit SARS-CoV-2?

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

U.S. vaccinates 131 million Americans against SARS-CoV-2

U.S. vaccinates 131 million Americans against SARS-CoV-2

Humans versus viruses - Can we avoid extinction in near future?

Humans versus viruses - Can we avoid extinction in near future?

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

Research looks at SARS-CoV-2 transmission from people to pets

Research looks at SARS-CoV-2 transmission from people to pets